Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| IRADIMED CORPIRMD · Entity 4896 | Director · CEO, President, Chairman · 10% owner | June 01, 2026 | June 02, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
IRADIMED CORP
Report date June 01, 2026 · Filed June 02, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectBy Phillip Susi 2008 Dynasty Trust | 2,164,600 |
Reported balance
After 2026-06-01 transaction · row 1
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 1 · 2026-06-01 · Sale · Disposed 400 · Balance 2,164,600 F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2025. F2: This transaction was executed in multiple trades at prices ranging from $88.10 to $88.87. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| Common StockSEC Table I · non-derivative | IndirectBy Phillip Susi 2008 Dynasty Trust | 2,163,825 |
Reported balance
After 2026-06-01 transaction · row 2
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 2 · 2026-06-01 · Sale · Disposed 775 · Balance 2,163,825 F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2025. F3: This transaction was executed in multiple trades at prices ranging from $89.29 to $90.15. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| Common StockSEC Table I · non-derivative | IndirectBy Phillip Susi 2008 Dynasty Trust | 2,163,424 |
Reported balance
After 2026-06-01 transaction · row 3
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 3 · 2026-06-01 · Sale · Disposed 401 · Balance 2,163,424 F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2025. F4: This transaction was executed in multiple trades at prices ranging from $90.69 to $91.58. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| Common StockSEC Table I · non-derivative | IndirectBy Phillip Susi 2008 Dynasty Trust | 2,162,500 |
Reported balance
After 2026-06-01 transaction · row 4
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 4 · 2026-06-01 · Sale · Disposed 924 · Balance 2,162,500 F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2025. F5: This transaction was executed in multiple trades at prices ranging from $91.75 to $92.08. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| Common StockSEC Table I · non-derivative | IndirectBy Roger E. Susi Revocable Trust | 162,950 |
Reported balance
Holding disclosure · report date 2026-06-01 · row 5
Holding and transaction disclosures are not merged.
1 source rowRow 5 · Balance 162,950 |
| Common StockSEC Table I · non-derivative | IndirectBy Matthew Susi 2008 Dynasty Trust | 2,062,500 |
Reported balance
Holding disclosure · report date 2026-06-01 · row 6
Holding and transaction disclosures are not merged.
1 source rowRow 6 · Balance 2,062,500 F6: The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all the reported shares for purposes of Section 16 or for any other purpose. |
Filing footnotes · ownership attribution and instrument terms
F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2025.
F2: This transaction was executed in multiple trades at prices ranging from $88.10 to $88.87. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F3: This transaction was executed in multiple trades at prices ranging from $89.29 to $90.15. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F4: This transaction was executed in multiple trades at prices ranging from $90.69 to $91.58. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F5: This transaction was executed in multiple trades at prices ranging from $91.75 to $92.08. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F6: The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all the reported shares for purposes of Section 16 or for any other purpose.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 01, 2026 Filed Jun 2, 2026 18:26 UTC | IRADIMED CORP IRMD · Entity 4896 | SaleCommon Stock | 924 | $91.91 | $84,924.84 |
DisclosureSEC source: 0001613801-26-000043 · wk-form4_1780424773.xml · nonDerivative · entry 4 Susi Roger E. · CIK 0001613801 · Director · CEO, President, Chairman · 10% owner 10b5-1 filing: Plan reported Ownership: Indirect · By Phillip Susi 2008 Dynasty Trust Disclosed balance after: 2,162,500 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2025. F5 · price: This transaction was executed in multiple trades at prices ranging from $91.75 to $92.08. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| June 01, 2026 Filed Jun 2, 2026 18:26 UTC | IRADIMED CORP IRMD · Entity 4896 | SaleCommon Stock | 401 | $91.08 | $36,523.08 |
DisclosureSEC source: 0001613801-26-000043 · wk-form4_1780424773.xml · nonDerivative · entry 3 Susi Roger E. · CIK 0001613801 · Director · CEO, President, Chairman · 10% owner 10b5-1 filing: Plan reported Ownership: Indirect · By Phillip Susi 2008 Dynasty Trust Disclosed balance after: 2,163,424 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2025. F4 · price: This transaction was executed in multiple trades at prices ranging from $90.69 to $91.58. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| June 01, 2026 Filed Jun 2, 2026 18:26 UTC | IRADIMED CORP IRMD · Entity 4896 | SaleCommon Stock | 775 | $89.79 | $69,587.25 |
DisclosureSEC source: 0001613801-26-000043 · wk-form4_1780424773.xml · nonDerivative · entry 2 Susi Roger E. · CIK 0001613801 · Director · CEO, President, Chairman · 10% owner 10b5-1 filing: Plan reported Ownership: Indirect · By Phillip Susi 2008 Dynasty Trust Disclosed balance after: 2,163,825 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2025. F3 · price: This transaction was executed in multiple trades at prices ranging from $89.29 to $90.15. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| June 01, 2026 Filed Jun 2, 2026 18:26 UTC | IRADIMED CORP IRMD · Entity 4896 | SaleCommon Stock | 400 | $88.68 | $35,472.00 |
DisclosureSEC source: 0001613801-26-000043 · wk-form4_1780424773.xml · nonDerivative · entry 1 Susi Roger E. · CIK 0001613801 · Director · CEO, President, Chairman · 10% owner 10b5-1 filing: Plan reported Ownership: Indirect · By Phillip Susi 2008 Dynasty Trust Disclosed balance after: 2,164,600 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2025. F2 · price: This transaction was executed in multiple trades at prices ranging from $88.10 to $88.87. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| May 27, 2026 Filed May 28, 2026 19:08 UTC | IRADIMED CORP IRMD · Entity 4896 | SaleCommon Stock | 333 | $92.61 | $30,839.13 |
DisclosureSEC source: 0001613801-26-000041 · wk-form4_1779995294.xml · nonDerivative · entry 4 Susi Roger E. · CIK 0001613801 · Director · CEO, President, Chairman · 10% owner 10b5-1 filing: Plan reported Ownership: Indirect · By Phillip Susi 2008 Dynasty Trust Disclosed balance after: 2,165,000 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2025. F5 · price: This transaction was executed in multiple trades at prices ranging from $92.54 to $93.11. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| May 27, 2026 Filed May 28, 2026 19:08 UTC | IRADIMED CORP IRMD · Entity 4896 | SaleCommon Stock | 2,167 | $91.85 | $199,038.95 |
DisclosureSEC source: 0001613801-26-000041 · wk-form4_1779995294.xml · nonDerivative · entry 3 Susi Roger E. · CIK 0001613801 · Director · CEO, President, Chairman · 10% owner 10b5-1 filing: Plan reported Ownership: Indirect · By Phillip Susi 2008 Dynasty Trust Disclosed balance after: 2,165,333 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2025. F4 · price: This transaction was executed in multiple trades at prices ranging from $91.41 to $92.38. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| May 26, 2026 Filed May 28, 2026 19:08 UTC | IRADIMED CORP IRMD · Entity 4896 | SaleCommon Stock | 1,889 | $92.93 | $175,544.77 |
DisclosureSEC source: 0001613801-26-000041 · wk-form4_1779995294.xml · nonDerivative · entry 2 Susi Roger E. · CIK 0001613801 · Director · CEO, President, Chairman · 10% owner 10b5-1 filing: Plan reported Ownership: Indirect · By Phillip Susi 2008 Dynasty Trust Disclosed balance after: 2,167,500 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2025. F3 · price: This transaction was executed in multiple trades at prices ranging from $92.70 to $93.14. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| May 26, 2026 Filed May 28, 2026 19:08 UTC | IRADIMED CORP IRMD · Entity 4896 | SaleCommon Stock | 3,111 | $91.81 | $285,620.91 |
DisclosureSEC source: 0001613801-26-000041 · wk-form4_1779995294.xml · nonDerivative · entry 1 Susi Roger E. · CIK 0001613801 · Director · CEO, President, Chairman · 10% owner 10b5-1 filing: Plan reported Ownership: Indirect · By Phillip Susi 2008 Dynasty Trust Disclosed balance after: 2,169,389 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2025. F2 · price: This transaction was executed in multiple trades at prices ranging from $91.35 to $92.30. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| May 19, 2026 Filed May 20, 2026 20:38 UTC | IRADIMED CORP IRMD · Entity 4896 | SaleCommon Stock | 6 | $88.65 | $531.90 |
DisclosureSEC source: 0001613801-26-000038 · wk-form4_1779309510.xml · nonDerivative · entry 6 Susi Roger E. · CIK 0001613801 · Director · CEO, President, Chairman · 10% owner 10b5-1 filing: Plan reported Ownership: Indirect · By Phillip Susi 2008 Dynasty Trust Disclosed balance after: 2,172,500 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2025. Read SEC document |
| May 19, 2026 Filed May 20, 2026 20:38 UTC | IRADIMED CORP IRMD · Entity 4896 | SaleCommon Stock | 1,841 | $88.14 | $162,265.74 |
DisclosureSEC source: 0001613801-26-000038 · wk-form4_1779309510.xml · nonDerivative · entry 5 Susi Roger E. · CIK 0001613801 · Director · CEO, President, Chairman · 10% owner 10b5-1 filing: Plan reported Ownership: Indirect · By Phillip Susi 2008 Dynasty Trust Disclosed balance after: 2,172,506 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2025. F6 · price: This transaction was executed in multiple trades at prices ranging from $87.62 to $88.54. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| May 19, 2026 Filed May 20, 2026 20:38 UTC | IRADIMED CORP IRMD · Entity 4896 | SaleCommon Stock | 653 | $87.13 | $56,895.89 |
DisclosureSEC source: 0001613801-26-000038 · wk-form4_1779309510.xml · nonDerivative · entry 4 Susi Roger E. · CIK 0001613801 · Director · CEO, President, Chairman · 10% owner 10b5-1 filing: Plan reported Ownership: Indirect · By Phillip Susi 2008 Dynasty Trust Disclosed balance after: 2,174,347 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2025. F5 · price: This transaction was executed in multiple trades at prices ranging from $86.60 to $87.44. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| May 18, 2026 Filed May 20, 2026 20:38 UTC | IRADIMED CORP IRMD · Entity 4896 | SaleCommon Stock | 1,251 | $88.34 | $110,513.34 |
DisclosureSEC source: 0001613801-26-000038 · wk-form4_1779309510.xml · nonDerivative · entry 3 Susi Roger E. · CIK 0001613801 · Director · CEO, President, Chairman · 10% owner 10b5-1 filing: Plan reported Ownership: Indirect · By Phillip Susi 2008 Dynasty Trust Disclosed balance after: 2,175,000 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2025. F4 · price: This transaction was executed in multiple trades at prices ranging from $87.90 to $88.73. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| May 18, 2026 Filed May 20, 2026 20:38 UTC | IRADIMED CORP IRMD · Entity 4896 | SaleCommon Stock | 3,451 | $87.35 | $301,444.85 |
DisclosureSEC source: 0001613801-26-000038 · wk-form4_1779309510.xml · nonDerivative · entry 2 Susi Roger E. · CIK 0001613801 · Director · CEO, President, Chairman · 10% owner 10b5-1 filing: Plan reported Ownership: Indirect · By Phillip Susi 2008 Dynasty Trust Disclosed balance after: 2,176,251 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2025. F3 · price: This transaction was executed in multiple trades at prices ranging from $86.89 to $87.85. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| May 18, 2026 Filed May 20, 2026 20:38 UTC | IRADIMED CORP IRMD · Entity 4896 | SaleCommon Stock | 298 | $85.95 | $25,613.10 |
DisclosureSEC source: 0001613801-26-000038 · wk-form4_1779309510.xml · nonDerivative · entry 1 Susi Roger E. · CIK 0001613801 · Director · CEO, President, Chairman · 10% owner 10b5-1 filing: Plan reported Ownership: Indirect · By Phillip Susi 2008 Dynasty Trust Disclosed balance after: 2,179,702 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2025. F2 · price: This transaction was executed in multiple trades at prices ranging from $85.67 to $86.54. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| May 12, 2026 Filed May 13, 2026 20:30 UTC | IRADIMED CORP IRMD · Entity 4896 | SaleCommon Stock | 1,104 | $84.59 | $93,387.36 |
DisclosureSEC source: 0001613801-26-000034 · wk-form4_1778704204.xml · nonDerivative · entry 5 Susi Roger E. · CIK 0001613801 · Director · CEO, President, Chairman · 10% owner 10b5-1 filing: Plan reported Ownership: Indirect · By Phillip Susi 2008 Dynasty Trust Disclosed balance after: 2,180,000 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2025. F6 · price: This transaction was executed in multiple trades at prices ranging from $84.17 to $84.88. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| May 12, 2026 Filed May 13, 2026 20:30 UTC | IRADIMED CORP IRMD · Entity 4896 | SaleCommon Stock | 3,307 | $83.70 | $276,795.90 |
DisclosureSEC source: 0001613801-26-000034 · wk-form4_1778704204.xml · nonDerivative · entry 4 Susi Roger E. · CIK 0001613801 · Director · CEO, President, Chairman · 10% owner 10b5-1 filing: Plan reported Ownership: Indirect · By Phillip Susi 2008 Dynasty Trust Disclosed balance after: 2,181,104 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2025. F5 · price: This transaction was executed in multiple trades at prices ranging from $83.11 to $84.06. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| May 11, 2026 Filed May 13, 2026 20:30 UTC | IRADIMED CORP IRMD · Entity 4896 | SaleCommon Stock | 315 | $85.90 | $27,058.50 |
DisclosureSEC source: 0001613801-26-000034 · wk-form4_1778704204.xml · nonDerivative · entry 3 Susi Roger E. · CIK 0001613801 · Director · CEO, President, Chairman · 10% owner 10b5-1 filing: Plan reported Ownership: Indirect · By Phillip Susi 2008 Dynasty Trust Disclosed balance after: 2,184,411 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2025. F4 · price: This transaction was executed in multiple trades at prices ranging from $85.78 to $86.00. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| May 11, 2026 Filed May 13, 2026 20:30 UTC | IRADIMED CORP IRMD · Entity 4896 | SaleCommon Stock | 1,001 | $84.94 | $85,024.94 |
DisclosureSEC source: 0001613801-26-000034 · wk-form4_1778704204.xml · nonDerivative · entry 2 Susi Roger E. · CIK 0001613801 · Director · CEO, President, Chairman · 10% owner 10b5-1 filing: Plan reported Ownership: Indirect · By Phillip Susi 2008 Dynasty Trust Disclosed balance after: 2,184,726 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2025. F3 · price: This transaction was executed in multiple trades at prices ranging from $84.73 to $85.73. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| May 11, 2026 Filed May 13, 2026 20:30 UTC | IRADIMED CORP IRMD · Entity 4896 | SaleCommon Stock | 1,773 | $84.08 | $149,073.84 |
DisclosureSEC source: 0001613801-26-000034 · wk-form4_1778704204.xml · nonDerivative · entry 1 Susi Roger E. · CIK 0001613801 · Director · CEO, President, Chairman · 10% owner 10b5-1 filing: Plan reported Ownership: Indirect · By Phillip Susi 2008 Dynasty Trust Disclosed balance after: 2,185,727 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2025. F2 · price: This transaction was executed in multiple trades at prices ranging from $83.66 to $84.62. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| May 05, 2026 Filed May 6, 2026 17:51 UTC | IRADIMED CORP IRMD · Entity 4896 | SaleCommon Stock | 178 | $87.31 | $15,541.18 |
DisclosureSEC source: 0001613801-26-000030 · wk-form4_1778089885.xml · nonDerivative · entry 7 Susi Roger E. · CIK 0001613801 · Director · CEO, President, Chairman · 10% owner 10b5-1 filing: Plan reported Ownership: Indirect · By Phillip Susi 2008 Dynasty Trust Disclosed balance after: 2,187,500 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2025. F7 · price: This transaction was executed in multiple trades at prices ranging from $86.94 to $87.40. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| May 05, 2026 Filed May 6, 2026 17:51 UTC | IRADIMED CORP IRMD · Entity 4896 | SaleCommon Stock | 1,650 | $86.43 | $142,609.50 |
DisclosureSEC source: 0001613801-26-000030 · wk-form4_1778089885.xml · nonDerivative · entry 6 Susi Roger E. · CIK 0001613801 · Director · CEO, President, Chairman · 10% owner 10b5-1 filing: Plan reported Ownership: Indirect · By Phillip Susi 2008 Dynasty Trust Disclosed balance after: 2,187,678 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2025. F6 · price: This transaction was executed in multiple trades at prices ranging from $85.93 to $86.93. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| May 05, 2026 Filed May 6, 2026 17:51 UTC | IRADIMED CORP IRMD · Entity 4896 | SaleCommon Stock | 1,322 | $85.56 | $113,110.32 |
DisclosureSEC source: 0001613801-26-000030 · wk-form4_1778089885.xml · nonDerivative · entry 5 Susi Roger E. · CIK 0001613801 · Director · CEO, President, Chairman · 10% owner 10b5-1 filing: Plan reported Ownership: Indirect · By Phillip Susi 2008 Dynasty Trust Disclosed balance after: 2,189,328 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2025. F5 · price: This transaction was executed in multiple trades at prices ranging from $84.90 to $85.86. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| May 05, 2026 Filed May 6, 2026 17:51 UTC | IRADIMED CORP IRMD · Entity 4896 | SaleCommon Stock | 600 | $83.78 | $50,268.00 |
DisclosureSEC source: 0001613801-26-000030 · wk-form4_1778089885.xml · nonDerivative · entry 4 Susi Roger E. · CIK 0001613801 · Director · CEO, President, Chairman · 10% owner 10b5-1 filing: Plan reported Ownership: Indirect · By Phillip Susi 2008 Dynasty Trust Disclosed balance after: 2,190,650 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2025. F4 · price: This transaction was executed in multiple trades at prices ranging from $83.42 to $84.34. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| May 04, 2026 Filed May 6, 2026 17:51 UTC | IRADIMED CORP IRMD · Entity 4896 | SaleCommon Stock | 200 | $87.05 | $17,410.00 |
DisclosureSEC source: 0001613801-26-000030 · wk-form4_1778089885.xml · nonDerivative · entry 3 Susi Roger E. · CIK 0001613801 · Director · CEO, President, Chairman · 10% owner 10b5-1 filing: Plan reported Ownership: Indirect · By Phillip Susi 2008 Dynasty Trust Disclosed balance after: 2,191,250 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2025. Read SEC document |
| May 04, 2026 Filed May 6, 2026 17:51 UTC | IRADIMED CORP IRMD · Entity 4896 | SaleCommon Stock | 1,103 | $86.26 | $95,144.78 |
DisclosureSEC source: 0001613801-26-000030 · wk-form4_1778089885.xml · nonDerivative · entry 2 Susi Roger E. · CIK 0001613801 · Director · CEO, President, Chairman · 10% owner 10b5-1 filing: Plan reported Ownership: Indirect · By Phillip Susi 2008 Dynasty Trust Disclosed balance after: 2,191,450 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2025. F3 · price: This transaction was executed in multiple trades at prices ranging from $85.91 to $86.71. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| May 04, 2026 Filed May 6, 2026 17:51 UTC | IRADIMED CORP IRMD · Entity 4896 | SaleCommon Stock | 2,447 | $85.32 | $208,778.04 |
DisclosureSEC source: 0001613801-26-000030 · wk-form4_1778089885.xml · nonDerivative · entry 1 Susi Roger E. · CIK 0001613801 · Director · CEO, President, Chairman · 10% owner 10b5-1 filing: Plan reported Ownership: Indirect · By Phillip Susi 2008 Dynasty Trust Disclosed balance after: 2,192,553 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2025. F2 · price: This transaction was executed in multiple trades at prices ranging from $84.86 to $85.82. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| April 28, 2026 Filed Apr 30, 2026 18:30 UTC | IRADIMED CORP IRMD · Entity 4896 | SaleCommon Stock | 263 | $88.81 | $23,357.03 |
DisclosureSEC source: 0001613801-26-000028 · wk-form4_1777573833.xml · nonDerivative · entry 7 Susi Roger E. · CIK 0001613801 · Director · CEO, President, Chairman · 10% owner 10b5-1 filing: Plan reported Ownership: Indirect · By Phillip Susi 2008 Dynasty Trust Disclosed balance after: 2,195,000 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2025. F8 · price: This transaction was executed in multiple trades at prices ranging from $88.66 to $88.95. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| April 28, 2026 Filed Apr 30, 2026 18:30 UTC | IRADIMED CORP IRMD · Entity 4896 | SaleCommon Stock | 900 | $88.00 | $79,200.00 |
DisclosureSEC source: 0001613801-26-000028 · wk-form4_1777573833.xml · nonDerivative · entry 6 Susi Roger E. · CIK 0001613801 · Director · CEO, President, Chairman · 10% owner 10b5-1 filing: Plan reported Ownership: Indirect · By Phillip Susi 2008 Dynasty Trust Disclosed balance after: 2,195,263 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2025. F7 · price: This transaction was executed in multiple trades at prices ranging from $87.65 to $88.60. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| April 28, 2026 Filed Apr 30, 2026 18:30 UTC | IRADIMED CORP IRMD · Entity 4896 | SaleCommon Stock | 742 | $86.52 | $64,197.84 |
DisclosureSEC source: 0001613801-26-000028 · wk-form4_1777573833.xml · nonDerivative · entry 5 Susi Roger E. · CIK 0001613801 · Director · CEO, President, Chairman · 10% owner 10b5-1 filing: Plan reported Ownership: Indirect · By Phillip Susi 2008 Dynasty Trust Disclosed balance after: 2,196,163 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2025. F6 · price: This transaction was executed in multiple trades at prices ranging from $86.21 to $87.16. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| April 28, 2026 Filed Apr 30, 2026 18:30 UTC | IRADIMED CORP IRMD · Entity 4896 | SaleCommon Stock | 847 | $85.77 | $72,647.19 |
DisclosureSEC source: 0001613801-26-000028 · wk-form4_1777573833.xml · nonDerivative · entry 4 Susi Roger E. · CIK 0001613801 · Director · CEO, President, Chairman · 10% owner 10b5-1 filing: Plan reported Ownership: Indirect · By Phillip Susi 2008 Dynasty Trust Disclosed balance after: 2,196,905 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2025. F5 · price: This transaction was executed in multiple trades at prices ranging from $85.20 to $86.08. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| April 28, 2026 Filed Apr 30, 2026 18:30 UTC | IRADIMED CORP IRMD · Entity 4896 | SaleCommon Stock | 998 | $84.13 | $83,961.74 |
DisclosureSEC source: 0001613801-26-000028 · wk-form4_1777573833.xml · nonDerivative · entry 3 Susi Roger E. · CIK 0001613801 · Director · CEO, President, Chairman · 10% owner 10b5-1 filing: Plan reported Ownership: Indirect · By Phillip Susi 2008 Dynasty Trust Disclosed balance after: 2,197,752 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2025. F4 · price: This transaction was executed in multiple trades at prices ranging from $83.75 to $84.50. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| April 27, 2026 Filed Apr 30, 2026 18:30 UTC | IRADIMED CORP IRMD · Entity 4896 | SaleCommon Stock | 931 | $89.70 | $83,510.70 |
DisclosureSEC source: 0001613801-26-000028 · wk-form4_1777573833.xml · nonDerivative · entry 2 Susi Roger E. · CIK 0001613801 · Director · CEO, President, Chairman · 10% owner 10b5-1 filing: Plan reported Ownership: Indirect · By Phillip Susi 2008 Dynasty Trust Disclosed balance after: 2,198,750 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2025. F3 · price: This transaction was executed in multiple trades at prices ranging from $89.54 to $90.18. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| April 27, 2026 Filed Apr 30, 2026 18:30 UTC | IRADIMED CORP IRMD · Entity 4896 | SaleCommon Stock | 2,819 | $88.98 | $250,834.62 |
DisclosureSEC source: 0001613801-26-000028 · wk-form4_1777573833.xml · nonDerivative · entry 1 Susi Roger E. · CIK 0001613801 · Director · CEO, President, Chairman · 10% owner 10b5-1 filing: Plan reported Ownership: Indirect · By Phillip Susi 2008 Dynasty Trust Disclosed balance after: 2,199,681 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2025. F2 · price: This transaction was executed in multiple trades at prices ranging from $88.47 to $89.45. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| April 21, 2026 Filed Apr 22, 2026 19:03 UTC | IRADIMED CORP IRMD · Entity 4896 | SaleCommon Stock | 592 | $92.66 | $54,854.72 |
DisclosureSEC source: 0001613801-26-000026 · wk-form4_1776884627.xml · nonDerivative · entry 6 Susi Roger E. · CIK 0001613801 · Director · CEO, President, Chairman · 10% owner 10b5-1 filing: Plan reported Ownership: Indirect · By Phillip Susi 2008 Dynasty Trust Disclosed balance after: 2,202,500 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2025. F7 · price: This transaction was executed in multiple trades at prices ranging from $92.18 to $92.89. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| April 21, 2026 Filed Apr 22, 2026 19:03 UTC | IRADIMED CORP IRMD · Entity 4896 | SaleCommon Stock | 606 | $91.65 | $55,539.90 |
DisclosureSEC source: 0001613801-26-000026 · wk-form4_1776884627.xml · nonDerivative · entry 5 Susi Roger E. · CIK 0001613801 · Director · CEO, President, Chairman · 10% owner 10b5-1 filing: Plan reported Ownership: Indirect · By Phillip Susi 2008 Dynasty Trust Disclosed balance after: 2,203,092 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2025. F6 · price: This transaction was executed in multiple trades at prices ranging from $91.22 to $92.14. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| April 21, 2026 Filed Apr 22, 2026 19:03 UTC | IRADIMED CORP IRMD · Entity 4896 | SaleCommon Stock | 140 | $90.60 | $12,684.00 |
DisclosureSEC source: 0001613801-26-000026 · wk-form4_1776884627.xml · nonDerivative · entry 4 Susi Roger E. · CIK 0001613801 · Director · CEO, President, Chairman · 10% owner 10b5-1 filing: Plan reported Ownership: Indirect · By Phillip Susi 2008 Dynasty Trust Disclosed balance after: 2,203,698 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2025. F5 · price: This transaction was executed in multiple trades at prices ranging from $90.23 to $90.75. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| April 21, 2026 Filed Apr 22, 2026 19:03 UTC | IRADIMED CORP IRMD · Entity 4896 | SaleCommon Stock | 1,162 | $89.73 | $104,266.26 |
DisclosureSEC source: 0001613801-26-000026 · wk-form4_1776884627.xml · nonDerivative · entry 3 Susi Roger E. · CIK 0001613801 · Director · CEO, President, Chairman · 10% owner 10b5-1 filing: Plan reported Ownership: Indirect · By Phillip Susi 2008 Dynasty Trust Disclosed balance after: 2,203,838 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2025. F4 · price: This transaction was executed in multiple trades at prices ranging from $89.18 to $90.11. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| April 20, 2026 Filed Apr 22, 2026 19:03 UTC | IRADIMED CORP IRMD · Entity 4896 | SaleCommon Stock | 1,420 | $93.90 | $133,338.00 |
DisclosureSEC source: 0001613801-26-000026 · wk-form4_1776884627.xml · nonDerivative · entry 2 Susi Roger E. · CIK 0001613801 · Director · CEO, President, Chairman · 10% owner 10b5-1 filing: Plan reported Ownership: Indirect · By Phillip Susi 2008 Dynasty Trust Disclosed balance after: 2,205,000 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2025. F3 · price: This transaction was executed in multiple trades at prices ranging from $93.69 to $94.14. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| April 20, 2026 Filed Apr 22, 2026 19:03 UTC | IRADIMED CORP IRMD · Entity 4896 | SaleCommon Stock | 3,580 | $93.14 | $333,441.20 |
DisclosureSEC source: 0001613801-26-000026 · wk-form4_1776884627.xml · nonDerivative · entry 1 Susi Roger E. · CIK 0001613801 · Director · CEO, President, Chairman · 10% owner 10b5-1 filing: Plan reported Ownership: Indirect · By Phillip Susi 2008 Dynasty Trust Disclosed balance after: 2,206,420 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2025. F2 · price: This transaction was executed in multiple trades at prices ranging from $92.69 to $93.66. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| April 14, 2026 Filed Apr 15, 2026 18:37 UTC | IRADIMED CORP IRMD · Entity 4896 | SaleCommon Stock | 393 | $94.55 | $37,158.15 |
DisclosureSEC source: 0001613801-26-000024 · wk-form4_1776278241.xml · nonDerivative · entry 5 Susi Roger E. · CIK 0001613801 · Director · CEO, President, Chairman · 10% owner 10b5-1 filing: Plan reported Ownership: Indirect · By Phillip Susi 2008 Dynasty Trust Disclosed balance after: 2,210,000 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2025. F6 · price: This transaction was executed in multiple trades at prices ranging from $94.24 to $94.80. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| April 14, 2026 Filed Apr 15, 2026 18:37 UTC | IRADIMED CORP IRMD · Entity 4896 | SaleCommon Stock | 2,107 | $93.71 | $197,446.97 |
DisclosureSEC source: 0001613801-26-000024 · wk-form4_1776278241.xml · nonDerivative · entry 4 Susi Roger E. · CIK 0001613801 · Director · CEO, President, Chairman · 10% owner 10b5-1 filing: Plan reported Ownership: Indirect · By Phillip Susi 2008 Dynasty Trust Disclosed balance after: 2,210,393 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2025. F5 · price: This transaction was executed in multiple trades at prices ranging from $93.17 to $94.13. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| April 13, 2026 Filed Apr 15, 2026 18:37 UTC | IRADIMED CORP IRMD · Entity 4896 | SaleCommon Stock | 589 | $93.45 | $55,042.05 |
DisclosureSEC source: 0001613801-26-000024 · wk-form4_1776278241.xml · nonDerivative · entry 3 Susi Roger E. · CIK 0001613801 · Director · CEO, President, Chairman · 10% owner 10b5-1 filing: Plan reported Ownership: Indirect · By Phillip Susi 2008 Dynasty Trust Disclosed balance after: 2,212,500 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2025. F4 · price: This transaction was executed in multiple trades at prices ranging from $93.29 to $94.03. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| April 13, 2026 Filed Apr 15, 2026 18:37 UTC | IRADIMED CORP IRMD · Entity 4896 | SaleCommon Stock | 2,564 | $92.79 | $237,913.56 |
DisclosureSEC source: 0001613801-26-000024 · wk-form4_1776278241.xml · nonDerivative · entry 2 Susi Roger E. · CIK 0001613801 · Director · CEO, President, Chairman · 10% owner 10b5-1 filing: Plan reported Ownership: Indirect · By Phillip Susi 2008 Dynasty Trust Disclosed balance after: 2,213,089 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2025. F3 · price: This transaction was executed in multiple trades at prices ranging from $92.35 to $93.23. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| April 13, 2026 Filed Apr 15, 2026 18:37 UTC | IRADIMED CORP IRMD · Entity 4896 | SaleCommon Stock | 1,847 | $91.84 | $169,628.48 |
DisclosureSEC source: 0001613801-26-000024 · wk-form4_1776278241.xml · nonDerivative · entry 1 Susi Roger E. · CIK 0001613801 · Director · CEO, President, Chairman · 10% owner 10b5-1 filing: Plan reported Ownership: Indirect · By Phillip Susi 2008 Dynasty Trust Disclosed balance after: 2,215,653 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2025. F2 · price: This transaction was executed in multiple trades at prices ranging from $91.28 to $92.22. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| April 07, 2026 Filed Apr 7, 2026 19:26 UTC | IRADIMED CORP IRMD · Entity 4896 | SaleCommon Stock | 982 | $95.58 | $93,859.56 |
DisclosureSEC source: 0001613801-26-000022 · wk-form4_1775589984.xml · nonDerivative · entry 5 Susi Roger E. · CIK 0001613801 · Director · CEO, President, Chairman · 10% owner 10b5-1 filing: Plan reported Ownership: Indirect · By Phillip Susi 2008 Dynasty Trust Disclosed balance after: 2,217,500 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2025. F6 · price: This transaction was executed in multiple trades at prices ranging from $95.17 to $95.95. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| April 07, 2026 Filed Apr 7, 2026 19:26 UTC | IRADIMED CORP IRMD · Entity 4896 | SaleCommon Stock | 1,518 | $94.36 | $143,238.48 |
DisclosureSEC source: 0001613801-26-000022 · wk-form4_1775589984.xml · nonDerivative · entry 4 Susi Roger E. · CIK 0001613801 · Director · CEO, President, Chairman · 10% owner 10b5-1 filing: Plan reported Ownership: Indirect · By Phillip Susi 2008 Dynasty Trust Disclosed balance after: 2,218,482 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2025. F5 · price: This transaction was executed in multiple trades at prices ranging from $94.15 to $95.10. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| April 06, 2026 Filed Apr 7, 2026 19:26 UTC | IRADIMED CORP IRMD · Entity 4896 | SaleCommon Stock | 569 | $96.78 | $55,067.82 |
DisclosureSEC source: 0001613801-26-000022 · wk-form4_1775589984.xml · nonDerivative · entry 3 Susi Roger E. · CIK 0001613801 · Director · CEO, President, Chairman · 10% owner 10b5-1 filing: Plan reported Ownership: Indirect · By Phillip Susi 2008 Dynasty Trust Disclosed balance after: 2,220,000 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2025. F4 · price: This transaction was executed in multiple trades at prices ranging from $96.61 to $97.00. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| April 06, 2026 Filed Apr 7, 2026 19:26 UTC | IRADIMED CORP IRMD · Entity 4896 | SaleCommon Stock | 3,074 | $96.24 | $295,841.76 |
DisclosureSEC source: 0001613801-26-000022 · wk-form4_1775589984.xml · nonDerivative · entry 2 Susi Roger E. · CIK 0001613801 · Director · CEO, President, Chairman · 10% owner 10b5-1 filing: Plan reported Ownership: Indirect · By Phillip Susi 2008 Dynasty Trust Disclosed balance after: 2,220,569 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2025. F3 · price: This transaction was executed in multiple trades at prices ranging from $95.61 to $96.54. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| April 06, 2026 Filed Apr 7, 2026 19:26 UTC | IRADIMED CORP IRMD · Entity 4896 | SaleCommon Stock | 1,357 | $95.21 | $129,199.97 |
DisclosureSEC source: 0001613801-26-000022 · wk-form4_1775589984.xml · nonDerivative · entry 1 Susi Roger E. · CIK 0001613801 · Director · CEO, President, Chairman · 10% owner 10b5-1 filing: Plan reported Ownership: Indirect · By Phillip Susi 2008 Dynasty Trust Disclosed balance after: 2,223,643 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2025. F2 · price: This transaction was executed in multiple trades at prices ranging from $94.54 to $95.54. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| March 30, 2026 Filed Apr 1, 2026 19:35 UTC | IRADIMED CORP IRMD · Entity 4896 | SaleCommon Stock | 155 | $96.53 | $14,962.15 |
DisclosureSEC source: 0001613801-26-000020 · wk-form4_1775072117.xml · nonDerivative · entry 3 Susi Roger E. · CIK 0001613801 · Director · CEO, President, Chairman · 10% owner 10b5-1 filing: Plan reported Ownership: Indirect · By Phillip Susi 2008 Dynasty Trust Disclosed balance after: 2,225,000 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2025. F4 · price: This transaction was executed in multiple trades at prices ranging from $96.50 to $97.16. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.